Outils numériques pour le suivi des patients allergiques. L’exemple du projet MASK-air

Bousquet, Jean; Arnavielhe, Sylvie; Bedbrook, Anna; Bossé, Isabelle; Czarlewski, Wienczylawa; Demoly, Pascal; Devillier, Philippe; Dupas, Eve; Fontaine, J.-F.; Laune, Daniel; Pham‐Thi, N.; Thibaudon, M.

doi:10.1016/j.reval.2019.02.006

Cited by 2 publications

(4 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is a more objective assessment of the treatment of allergic rhinitis than patient complaints, as allergic rhinitis is known to be a variable disease and control is highly dependent on allergen exposure. Studies with "MASK-air" confirm that patients rarely adhere to the recommended treatment regimen, discontinue treatment when they feel better and consume more medications when symptoms worsen (28)(29)(30)(31). It has also been shown that patients who take multiple medicines have poorer disease control than those who take only one or no medicine at all (30).…”

Section: Mobile Apps and For Monitoring Allergic Rhinitismentioning

confidence: 99%

“…Studies with "MASK-air" confirm that patients rarely adhere to the recommended treatment regimen, discontinue treatment when they feel better and consume more medications when symptoms worsen (28)(29)(30)(31). It has also been shown that patients who take multiple medicines have poorer disease control than those who take only one or no medicine at all (30). Only less than 5% take their medication according to their doctor's recommendations (30).…”

Section: Mobile Apps and For Monitoring Allergic Rhinitismentioning

confidence: 99%

“…It has also been shown that patients who take multiple medicines have poorer disease control than those who take only one or no medicine at all (30). Only less than 5% take their medication according to their doctor's recommendations (30). Treatment guidelines assume that patients adhere to their treatment regimen, but clearly better patient education and involvement in the development of the treatment plan is needed (26).…”

Section: Mobile Apps and For Monitoring Allergic Rhinitismentioning

confidence: 99%

See 2 more Smart Citations

mHealth and telemedicine utility in the monitoring of allergic diseases

2022

View full text Add to dashboard Cite

This literature review discusses the use of mHealth technologies and telemedicine for monitoring various allergic diseases both in everyday life and in the context of COVID-19. Telemedicine, whose popularity, and demand has skyrocketed during the pandemic, rely on mHealth technologies, video calls and websites as a resource-saving and safe way of consulting patients. The incorporation of new mHealth technologies into telemedicine practice may not only be relevant in the context of pandemic restrictions but can also be applied in everyday medical practice as an effective method of patient counseling. The mobile healthcare applications include a wide range of mobile apps for patients' education, monitoring, and disease management. However, applications for the people with food allergies lack relevant information about allergies and, like most other applications, are developed without the contribution of healthcare specialists. During the COVID-19 pandemic, low-risk food-allergic patients were able to rely on telemedicine services where they could get the help, they needed without increasing risk of contracting COVID-19 while saving time. Meanwhile, some applications for allergic rhinitis and asthma patients are showing practical benefits in clinical trials by allowing an efficient assessment of treatment regimens and efficacy. The use of digital symptom diaries further facilitates the implementation of real-life studies. However, for respiratory allergic diseases, the often insufficient quality of pollen prediction needs to be taken into account. Even though studies have shown that asthma is better controlled with mHealth technologies, the quality of mobile apps for asthma patients varies widely, as many products provide information that has not been scientifically proven. Inhaler sensors – have been shown to improve the course of asthma and its monitoring, while push notifications prompting people to take their medication double the likelihood of treatment adherence. Teledermatology has a high level of patient satisfaction – as it is perceived as a more time-saving method of consultation. However, the diagnostic accuracy of contact consultations remains higher. mHealth technologies provide a patient's health data from his/her daily life, which enables insights into behavioral patterns. This closer look at the daily routine can have a significant impact on developing individualized treatment and care guidelines.

show abstract

Section: Mobile Apps and For Monitoring Allergic Rhinitismentioning

confidence: 99%

Section: Mobile Apps and For Monitoring Allergic Rhinitismentioning

confidence: 99%

Section: Mobile Apps and For Monitoring Allergic Rhinitismentioning

confidence: 99%

See 1 more Smart Citation

mHealth and telemedicine utility in the monitoring of allergic diseases

2022

View full text Add to dashboard Cite

show abstract

“…Digital solution to care and to manage AR and asthma multimorbidity promotes evidencebased information and enables patients to provide their doctors with feedback and data on their health (66)(67)(68)(69)(70)(71). There are online virtual community platforms to support people remotely, some new smart inhalers, and mobile healthcare system for asthma (66)(67)(68)(69)(70)(71).…”

Section: Accepted Manuscriptmentioning

confidence: 99%

Manifesto on united airways diseases (UAD): an Interasma (global asthma association – GAA) document

et al. 2021

View full text Add to dashboard Cite

The large amount of evidence and the renewed interest on upper and lower airways involvement in infectious and inflammatory diseases has led Interasma (Global Asthma Association) to take a position on United Airways Diseases (UAD). Starting from an extensive literature review, Interasma excecutive committee discussed and approved this Manifesto developed by Interasma scientific network (INES) members. The manifesto describes the evidence gathered to date and defines, states, advocates, and proposes issues on UAD (rhinitis, rhinosinusitis and nasal polyposis), and concomitant/comorbid lower airways disorders (asthma, chronic obstructive pulmonary disease, bronchiectasis, cystic fibrosis, obstructive sleep apnoea) with the aim of challenging assumptions, fostering commitment, and bringing about change.UAD refer to clinical pictures characterized by the coexistence of upper and lower airways involvement, driven by a common pathophysiological mechanism, leading to a greater burden on patient's health status and requiring an integrated diagnostic and therapeutic plan.The high prevalence of UAD must be taken into account. Upper and lower airways diseases influence disease control and patient's quality of life. Patients with UAD need to have a timely and adequate diagnosis, treatment, and, when recommended, referral for management in a specialized center. Diagnostic testing including skin prick or serum specific IgE, lung function, fractional exhaled nitric oxide (FeNO), polysomnography, allergen-specific immunotherapies, biological therapies and homebased continuous positive airway pressure (CPAP) whenever these are recommended, should be part of the management plan for UAD.Education of medical students, physicians, health professionals, patients and caregivers on the UAD is needed.

show abstract

Outils numériques pour le suivi des patients allergiques. L’exemple du projet MASK-air

Cited by 2 publications

References 10 publications

mHealth and telemedicine utility in the monitoring of allergic diseases

mHealth and telemedicine utility in the monitoring of allergic diseases

Manifesto on united airways diseases (UAD): an Interasma (global asthma association – GAA) document

Contact Info

Product

Resources

About